Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4601-4608

  Reddy, Narsa M ^a   Suryanarayana, Vegiraju ^a   Kalvakolanu, Dhananjaya V ^b   Yamamoto, Masayuki ^c   Kensler, Thomas W ^a   Hassoun, Paul M ^d   Kleeberger, Steven R ^e   Reddy, Sekhar P ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c TOHOKU UNIVERSITY   (Japan)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROPHILE; INTERLEUKIN 6; TRANSCRIPTION FACTOR NRF2; AUTACOID; NFE2L2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPEROXIA; IN VITRO STUDY; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BACTERIAL PNEUMONIA; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; GENE EXPRESSION REGULATION, BACTERIAL; HYPEROXIA; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS;

EID: 70449723401     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901754     Document Type: Article

References (49)

1. Crapo, J. D. 1986. Morphologic changes in pulmonary oxygen toxicity. Annu. Rev. Physiol. 48: 721-731.
2. Crapo, J. D., B. E. Barry, H. A. Foscue, and J. Shelburne. 1980. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am. Rev. Respir. Dis. 122: 123-143.
3. Pagano, A., and C. Barazzone-Argiroffo. 2003. Alveolar cell death in hyperoxia-induced lung injury. Ann. NY Acad. Sci. 1010: 405-416. (Pubitemid 38265016)
4. Chabot, F., J. A. Mitchell, J. M. Gutteridge, and T. W. Evans. 1998. Reactive oxygen species in acute lung injury. Eur. Respir. J. 11: 745-757. (Pubitemid 28194873)
5. Comhair, S. A., and S. C. Erzurum. 2002. Antioxidant responses to oxidant-mediated lung diseases. Am. J. Physiol. 283: L246-L255.
6. Nguyen, T., P. J. Sherratt, and C. B. Pickett. 2003. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43: 233-260. (Pubitemid 37372641)
7. Cho, H. Y., S. P. Reddy, and S. R. Kleeberger. 2006. Nrf2 defends the lung from oxidative stress. Antioxid. Redox Signal. 8: 76-87. (Pubitemid 43324533)
8. Cho, H.-Y., A. E. Jedlicka, S. P. M. Reddy, T. W. Kensler, M. Yamamoto, L.-Y. Zhang, and S. R. Kleeberger. 2002. Role of Nrf2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26: 175-182. (Pubitemid 34107870)
9. Cho, H. Y., S. P. Reddy, M. Yamamoto, and S. R. Kleeberger. 2004. The transcription factor Nrf2 protects against pulmonary fibrosis. FASEB J. 18: 1258-1260.
10. Reddy, N. M., S. R. Kleeberger, H. Y. Cho, M. Yamamoto, T. W. Kensler, S. Biswal, and S. P. Reddy. 2007. Deficiency in Nrf2-GSH signaling impairs type II cell growth and enhances sensitivity to oxidants. Am. J Respir. Cell Mol. Biol. 37: 3-8.
11. Reddy, N. M., S. R. Kleeberger, J. H. Bream, P. G. Fallon, T. W. Kensler, M. Yamamoto, and S. P. Reddy. 2008. Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling. Oncogene 27: 5821-5832.
12. Reddy, N. M., S. R. Kleeberger, T. W. Kensler, M. Yamamoto, P. M. Hassoun, and S. P. Reddy. 2009. Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. J. Immunol. 182: 7264-7271.
13. Chastre, J., and J. Y. Fagon. 2002. Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 165: 867-903.
14. Davey, M. E., N. C. Caiazza, and G. A. O'Toole. 2003. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J. Bacteriol. 185: 1027-1036.
15. Sadikot, R. T., T. S. Blackwell, J. W. Christman, and A. S. Prince. 2005. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171: 1209-1223. (Pubitemid 40740727)
16. McNamee, L. A., and A. G. Harmsen. 2006. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect. Immun. 74: 6707-6721.
17. Dockrell, D. H., H. M. Marriott, L. R. Prince, V. C. Ridger, P. G. Ince, P. G. Hellewell, and M. K. Whyte. 2003. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J. Immunol. 171: 5380-5388.
18. Thakur, S. A., R. F. Hamilton, Jr., and A. Holian. 2008. Role of scavenger receptor a family in lung inflammation from exposure to environmental particles. J. Immunotoxicol. 5: 151-157.
19. Palecanda, A., and L. Kobzik. 2001. Receptors for unopsonized particles: the role of alveolar macrophage scavenger receptors. Curr. Mol. Med. 1: 589-595. (Pubitemid 33772037)
20. Dunn, M. M., and L. J. Smith. 1986. The effects of hyperoxia on pulmonary clearance of Pseudomonas aeruginosa. J. Infect. Dis. 153: 676-681. (Pubitemid 16133748)
21. Harada, R. N., A. E. Vatter, and J. E. Repine. 1984. Macrophage effector function in pulmonary oxygen toxicity: hyperoxia damages and stimulates alveolar macrophages to make and release chemotaxins for polymorphonuclear leukocytes. J. Leukocyte Biol. 35: 373-383.
22. Suntres, Z. E., A. Omri, and P. N. Shek. 2002. Pseudomonas aeruginosa-induced lung injury: role of oxidative stress. Microb. Pathog. 32: 27-34.
23. O'Reilly, P. J., J. M. Hickman-Davis, I. C. Davis, and S. Matalon. 2003. Hyperoxia impairs antibacterial function of macrophages through effects on actin. Am. J. Respir. Cell Mol. Biol. 28: 443-450.
24. Tateda, K., J. C. Deng, T. A. Moore, M. W. Newstead, R. Paine, 3rd, N. Kobayashi, K. Yamaguchi, and T. J. Standiford. 2003. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J. Immunol. 170: 4209-4216.
25. Baleeiro, C. E., S. E. Wilcoxen, S. B. Morris, T. J. Standiford, and R. Paine, 3rd. 2003. Sublethal hyperoxia impairs pulmonary innate immunity. J. Immunol. 171: 955-963.
26. Kikuchi, Y., K. Tateda, E. T. Fuse, T. Matsumoto, N. Gotoh, J. Fukushima, H. Takizawa, T. Nagase, T. J. Standiford, and K. Yamaguchi. 2009. Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia. Pulm. Pharmacol. Ther.
27. Markowicz, P., M. Wolff, K. Djedaini, Y. Cohen, J. Chastre, C. Delclaux, J. Merrer, B. Herman, B. Veber, A. Fontaine, and D. Dreyfuss. 2000. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. Am. J. Respir. Crit. Care Med. 161: 1942-1948.
28. Marzec, J. M., J. D. Christie, S. P. Reddy, A. E. Jedlicka, H. Vuong, P. N. Lanken, R. Aplenc, T. Yamamoto, M. Yamamoto, H. Y. Cho, and S. R. Kleeberger. 2007. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J. 21: 2237-2246.
29. Arisawa, T., T. Tahara, T. Shibata, M. Nagasaka, M. Nakamura, Y. Kamiya, H. Fujita, S. Hasegawa, T. Takagi, F. Y. Wang, et al. 2007. The relationship between Helicobacter pylori infection and promoter polymorphism of the NRF2 gene in chronic gastritis. Int. J. Mol. Med. 19: 143-148.
30. Arisawa, T., T. Tahara, T. Shibata, M. Nagasaka, M. Nakamura, Y. Kamiya, H. Fujita, D. Yoshioka, Y. Arima, M. Okubo, et al. 2008. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium. Oncol. Rep. 19: 211-216.
31. Arisawa, T., T. Tahara, T. Shibata, M. Nagasaka, M. Nakamura, Y. Kamiya, H. Fujita, D. Yoshioka, M. Okubo, M. Sakata, et al. 2008. NRF2 gene promoter polymorphism is associated with ulcerative colitis in a Japanese population. Hepatogastroenterology 55: 394-397. (Pubitemid 351741468)
32. Arisawa, T., T. Tahara, T. Shibata, M. Nagasaka, M. Nakamura, Y. Kamiya, H. Fujita, D. Yoshioka, Y. Arima, M. Okubo, et al. 2007. Association between promoter polymorphisms of nuclear factor-erythroid 2-related factor 2 gene and peptic ulcer diseases. Int. J. Mol. Med. 20: 849-853.
33. Marriott, H. M., and D. H. Dockrell. 2007. The role of the macrophage in lung disease mediated by bacteria. Exp. Lung Res. 33: 493-505.
34. Faurschou, M., and N. Borregaard. 2003. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5: 1317-1327.
35. Nauseef, W. M. 2007. How human neutrophils kill and degrade microbes: an integrated view. Immunol. Rev. 219: 88-102.
36. Rehm, S. R., G. N. Gross, and A. K. Pierce. 1980. Early bacterial clearance from murine lungs: species-dependent phagocyte response. J. Clin. Invest. 66: 194-199.
37. Raffin, T. A., L. M. Simon, D. Braun, J. Theodore, and E. D. Robin. 1980. Impairment of phagocytosis by moderate hyperoxia (40 to 60 per cent oxygen) in lung macrophages. Lab. Invest. 42: 622-626.
38. Zhou, H., and L. Kobzik. 2007. Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 36: 460-465.
39. Goldsmith, C. A., A. Imrich, H. Danaee, Y. Y. Ning, and L. Kobzik. 1998. Analysis of air pollution particulate-mediated oxidant stress in alveolar macrophages. J. Toxicol. Environ. Health A. 54: 529-545.
40. Becker, S., J. M. Soukup, and J. E. Gallagher. 2002. Differential particulate air pollution induced oxidant stress in human granulocytes, monocytes and alveolar macrophages. Toxicol. In Vitro 16: 209-218.
41. Dalle-Donne, I., D. Giustarini, R. Rossi, R. Colombo, and A. Milzani. 2003. Reversible S-glutathionylation of Cys 374 regulates actin filament formation by inducing structural changes in the actin molecule. Free Radical Biol. Med. 34: 23-32.
42. Fiaschi, T., G. Cozzi, G. Raugei, L. Formigli, G. Ramponi, and P. Chiarugi. 2006. Redox regulation of β-actin during integrin-mediated cell adhesion. J. Biol. Chem. 281: 22983-22991.
43. Segal, A. W. 2005. How neutrophils kill microbes. Annu. Rev. Immunol. 23: 197-223.
44. Dahl, M., A. K. Bauer, M. Arredouani, R. Soininen, K. Tryggvason, S. R. Kleeberger, and L. Kobzik. 2007. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J. Clin. Invest. 117: 757-764.
45. Kobayashi, H., N. Sakashita, T. Okuma, Y. Terasaki, K. Tsujita, H. Suzuki, T. Kodama, H. Nomori, M. Kawasuji, and M. Takeya. 2007. Class A scavenger receptor (CD204) attenuates hyperoxia-induced lung injury by reducing oxidative stress. J. Pathol. 212: 38-46.
46. Granucci, F., F. Petralia, M. Urbano, S. Citterio, F. Di Tota, L. Santambrogio, and P. Ricciardi-Castagnoli. 2003. The scavenger receptor MARCO mediates cytoskeleton rearrangements in dendritic cells and microglia. Blood 102: 2940-2947.
47. Arredouani, M., Z. Yang, Y. Ning, G. Qin, R. Soininen, K. Tryggvason, and L. Kobzik. 2004. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J. Exp. Med. 200: 267-272.
48. Beamer, C. A., and A. Holian. 2005. Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure. Am. J. Physiol. 289: L186-L195.
49. Thakur, S. A., C. A. Beamer, C. T. Migliaccio, and A. Holian. 2009. Critical role of MARCO in crystalline silica-induced pulmonary inflammation. Toxicol. Sci. 108: 462-471.